MedTrace Logo

Impact of COVID-19 on GU Disease

NCT04761107 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15240

Last updated 2025-01-31

No results posted yet for this study

Summary

The purpose of this research study is to identify patients with GU disease with active or past COVID-19 infection.

Participants will be asked to:

* Complete an Online COVID-19 Questionnaire.
* Disclose if the patient has or had Genitourinary cancer or benign urologic condition
* Provide urine specimen for research
* Provide 4 tablespoons of blood for testing blood for research.
* Provide permission to access medical records, such as patient lab results, medical history, imaging reports, etc.

Conditions

  • COVID-19 Infection
  • Genitourinary Cancer
  • Benign Urologic Conditions

Sponsors & Collaborators

Principal Investigators

  • Ashutosh K Tewari, MD · Icahn School of Medicine at Mount Sinai

  • Dimple Chakravarty, PhD · Icahn School of Medicine at Mount Sinai

  • Sujit S Nair, PhD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-18
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04761107 on ClinicalTrials.gov